INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sezzle Inc. - SEZL — Neutral
SEZL PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sezzle Inc. ("Sezzle" or the "Company") (NASDAQ: SEZL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ — Neutral
JNJ PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Johnson & Johnson. ("J&J" or the "Company") (NYSE: JNJ).

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Huntington Ingalls Industries, Inc. - HII — Neutral
HII PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Huntington Ingalls Industries, Inc. ("Huntington Ingalls" or the "Company") (NASDAQ: HII). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sonos, Inc. - SONO — Neutral
SONO PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sonos, Inc. ("Sonos" or the "Company") (NASDAQ: SONO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 4D Molecular Therapeutics, Inc. - FDMT — Neutral
FDMT PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of 4D Molecular Therapeutics, Inc. ("4D" or the "Company") (NASDAQ: FDMT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Skyworks Solutions, Inc. - SWKS — Neutral
SWKS PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Skyworks Solutions, Inc. ("Skyworks" or the "Company") (NASDAQ: SWKS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eldorado Gold Corporation - EGO — Neutral
EGO PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- LLP is investigating claims on behalf of investors of Eldorado Gold Corporation ("Eldorado" or the "Company") (NYSE: EGO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Proficient Auto Logistics Reports Preliminary Fourth Quarter 2024 Financial Results — Neutral
PAL Business Wire — February 11, 2025JACKSONVILLE, Fla.--(BUSINESS WIRE)--Proficient Auto Logistics, Inc. (NASDAQ: PAL) (the “Company” or “Proficient”) today reported its preliminary financial results for the three months ended December 31, 2024, and comparative summary financial information for the Founding Companies (as defined below) on a combined basis for the three months ended December 31, 2023. Fourth Quarter Summary (fourth quarter 2023 information on a combined basis) Total Operating Revenue of $95.1 million, increased 4%.

Gilead Sciences (GILD 0.69%), a major player in the biotechnology sector, reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 11, that topped analysts' consensus estimates. Adjusted earnings per share of $1.90 came in well ahead of the estimated $1.74.

Gold Price Forecast: Record Highs for Gold, but Weak Close Looms — Positive
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL FXEmpire — February 11, 2025Gold surged to $2,943, hitting record highs before facing resistance. A weak closing price increases the chances that a bearish reversal may follow, with $2,882 as key near-term support.

Quipt Home Medical Corp. (QIPT) Q1 2025 Earnings Call Transcript — Neutral
QIPT Seeking Alpha — February 11, 2025Quipt Home Medical Corp. (NASDAQ:QIPT ) Q1 2025 Earnings Conference Call February 11, 2025 10:00 AM ET Company Participants Greg Crawford - Chairman & Chief Executive Officer Hardik Mehta - Chief Financial Officer Conference Call Participants Richard Close - Canaccord Genuity Doug Cooper - Beacon Securities Julian Hung - Stifel Bill Sutherland - The Benchmark Company Operator Thank you for standing by. This is the conference operator.

Zurn Elkay Water Solutions Announces Launch of Public Offering of Common Stock by Selling Stockholder — Neutral
ZWS Business Wire — February 11, 2025MILWAUKEE--(BUSINESS WIRE)--Zurn Elkay Water Solutions Announces Launch of Public Offering of Common Stock by Selling Stockholder.

Everus Reports Strong Fourth Quarter and Full Year 2024 Results, Initiates Guidance for 2025 — Neutral
ECG Business Wire — February 11, 2025BISMARCK, N.D.--(BUSINESS WIRE)--Everus Construction Group (NYSE: ECG) today reported financial results for the fourth quarter and full year 2024.

Teledyne to Participate at the TD Cowen Aerospace & Defense Conference — Neutral
TDY Business Wire — February 11, 2025THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Teledyne Technologies Incorporated (NYSE:TDY) today announced that George Bobb, President and Chief Operating Officer, and Jason VanWees, Vice Chairman, will present at the TD Cowen 46th Annual Aerospace & Defense Conference at the Ritz-Carlton – Pentagon City in Arlington, Va. on Thursday, February 13, at 9:15 a.m. Eastern Time. A live webcast of Teledyne's presentation may be accessed via the company's website at www.teledyne.com/investors/events-an.

USA Compression Partners Announces Filing of 2024 Annual Report on Form 10-K — Neutral
USAC Business Wire — February 11, 2025DALLAS--(BUSINESS WIRE)--USA Compression Partners, LP (NYSE: USAC) (“USA Compression”) today announced that it filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, with the U.S. Securities and Exchange Commission (“SEC”). USA Compression's Annual Report on Form 10-K is available through its website at www.usacompression.com in the Investor Relations section under SEC Filings, as well as on the SEC's website at sec.gov. Interested investors may obtain a hard copy of.

Ford CEO says tariffs could 'blow a hole' in US auto industry — Negative
F Fox Business — February 11, 2025Ford CEO Jim Farley said at an analyst conference that while President Trump wants to help automakers, his Canada and Mexico tariffs could "blow a hole" in the U.S. auto industry.

Arcus Biosciences Announces New Employment Inducement Grants — Neutral
RCUS Business Wire — February 11, 2025HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today announced that, in connection with the appointment of the Company's new Chief Medical Officer, Richard Markus, M.D., Ph.D., the Compensation Committee of the Company's Board of Directors granted Dr. Markus an option to purchase 305,328 shares of the Company's common stock.

Loews: At $87 It's Undervalued Given Management's Persistent History Of Success — Positive
L Seeking Alpha — February 11, 2025Loews: At $87 It's Undervalued Given Management's Persistent History Of Success

Mexican telecoms giant America Movil's profit slides on FX losses — Negative
AMX Reuters — February 11, 2025Mexican telecommunications giant America Movil on Tuesday reported a 48% fall in its fourth-quarter net profit, well below analysts' expectations, with the company citing foreign-exchange losses even as its revenues rose.

NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Tidal Financial Group and Plato's Philosophy LLC announce the closure and liquidation of the Meet Kevin Pricing Power ETF (NYSE Arca: PP), effective February 28, 2025. This decision follows a thorough evaluation and was determined to be in the best interests of the fund and its shareholders.
